-+ 0.00%
-+ 0.00%
-+ 0.00%

CRISPR Therapeutics Files Initial Beneficial Ownership Statement for CFO Andrew Jacob Silver

PUBT·10/21/2026 21:36:35
Listen to the news
CRISPR Therapeutics Files Initial Beneficial Ownership Statement for CFO Andrew Jacob Silver
  • CRISPR Therapeutics Chief Financial Officer Andrew Jacob Silver filed an initial statement of beneficial ownership dated October 21, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CRISPR Therapeutics AG published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-428002), on October 21, 2026, and is solely responsible for the information contained therein.